GlaxoSmithKline | GSK - Market Capitalization



GlaxoSmithKline reported GBP61.07B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Alcon AG CHF 34.72B 6.87B Jun/2025
Almirall EUR 2.29B 195.31M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
argenx SE EUR 28.69B 4.16B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Fresenius EUR 24.04B 1.84B Jun/2025
Fresenius Medical Care EUR 14.27B 870.85M Jun/2025
Galapagos EUR 1.57B 31.54M Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Glaxosmithkline USD 82.21B 2.63B Sep/2025
GRIFOLS EUR 6.33B 1.14B Jun/2025
Hikma Pharmaceutical GBP 4.42B 226.35M Dec/2024
Merck EUR 47.83B 7.27B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Novo Nordisk A/S 1.96T 370.19B Jun/2025
Orion EUR 8.99B 1.28B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Philips EUR 19.65B 2.33B Jun/2025
Recordati EUR 10.98B 42.75M Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Smith & Nephew GBP 13.32B 4.65B Jun/2025